Amid concerns about the cost of the drug Repatha, pharmaceutical company Amgen is pledging money back guarantees, making its first such deal with Harvard Pilgrim Health Care. "We want to stand behind the value of our products. We want to put skin in the game," said one of Amgen's senior officials.
↧